Xtant Medical - XTNT Stock Forecast, Price & News

Xtant Medical saw a decline in short interest during the month of December. As of December 30th, there was short interest totaling 313,100 shares, a decline of 35.3% from the December 15th total of 484,300 shares. Based on an average daily volume of 35,700 shares, the short-interest ratio is presently 8.8 days. Approximately 1.3% of the shares of the company are sold short.
View Xtant Medical's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, March 6th 2023.
View our XTNT earnings forecast.

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) released its earnings results on Thursday, November, 3rd. The medical device company reported ($0.03) EPS for the quarter. The medical device company earned $14.46 million during the quarter. Xtant Medical had a negative net margin of 15.11% and a negative trailing twelve-month return on equity of 28.28%.

Xtant Medical's stock reverse split before market open on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Xtant Medical investors own include Aurinia Pharmaceuticals (AUPH), LadRx (CYTR), Protalix BioTherapeutics (PLX), Heat Biologics (HTBX), Neovasc (NVCN), Rexahn Pharmaceuticals (REXN), Biopharmx (BPMX), Adamis Pharmaceuticals (ADMP), Lipocine (LPCN) and Synergy Pharmaceuticals (SGYP).

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

Shares of XTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of XTNT stock can currently be purchased for approximately $0.69.

Xtant Medical (NYSEAMERICAN:XTNT) has a market capitalization of $74.98 million and generates $55.26 million in revenue each year. The medical device company earns $-4,850,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis.

The company employs 116 workers across the globe.

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The official website for the company is xtantmedical.com. The medical device company can be reached via phone at (406) 388-0480, via email at investorrelations@xtantmedical.com, or via fax at 406-388-1354.